2BBBullish & Bearish
Omnicell, Inc. (OMCL) trades on NASDAQ. It operates in the Health Care sector, Health Information Services industry. Its current 2BB score is 32 out of 100.
Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.
Omnicell, Inc.’s current 2BB score is 32 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 42 | Normal |
| Quality | 100 | Very Strong |
| Risk | 0 | Very Low |
| CEO | Randall A. Lipps |
| Headquarters | Mountain View, California, United States |
| Founded | Sep 1992 |
| Employees | 3.52K |
| P/E ratio | 97.52 |
| 52-week range | $26.84 – $55.00 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-03 | — | 0.3759 | — | $316.65M |
| 2026-10-28 | — | 0.424 | — | $310.56M |
| 2026-07-30 | — | 0.4769 | — | $316.46M |
| 2026-05-04 | — | 0.3277 | — | $310.07M |